O'Shaughnessy Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.22M Buy
14,787
+7,180
+94% +$781K 0.01% 873
2026
Q1
$703K Sell
7,607
-3,194
-30% -$321K ﹤0.01% 1357
2025
Q4
$1.1M Buy
10,801
+3,857
+56% +$345K 0.01% 1099
2025
Q3
$434K Buy
+6,944
New +$378K ﹤0.01% 1565
2021
Q4
– Sell
-167
Closed -$21K – 1715
2021
Q3
$21K Buy
167
+105
+169% +$12.5K ﹤0.01% 1931
2021
Q2
$8K Sell
62
-47
-43% -$6.32K ﹤0.01% 2040
2021
Q1
$17K Buy
109
+16
+17% +$2.42K ﹤0.01% 1669
2020
Q4
$12K Buy
93
+83
+830% +$9.55K ﹤0.01% 1514
2020
Q3
$1K Buy
+10
New +$915 ﹤0.01% 1738

Other funds holding GH

O'Shaughnessy Asset Management's GH Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its Guardant Health (GH) stake by 94% in Q2 2026, buying an estimated $781K and bringing the position to 14,787 shares worth $2.22M. The position accounts for 0.01% of the portfolio, ranked #873.

O'Shaughnessy Asset Management first reported a position in GH in Q3 2020 and has held it in 9 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • O'Shaughnessy Asset Management held 14,787 shares of Guardant Health worth $2.22M as of Q2 2026.
  • O'Shaughnessy Asset Management bought 7,180 Guardant Health shares in Q2 2026, an estimated $781K.
  • Guardant Health made up 0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #873 holding.
  • O'Shaughnessy Asset Management first reported a position in Guardant Health in Q3 2020 and has held it in 9 quarters since.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.